Biotech - Reprogrammed Cells That Hunt Cancer episode artwork

EPISODE · Apr 11, 2026 · 26 MIN

Biotech - Reprogrammed Cells That Hunt Cancer

from Biotech · host Inception Point AI

Ryan Cole explores CAR-T therapy, where patients' immune cells are genetically reprogrammed to hunt cancer. With FDA-approved treatments achieving 83% remission rates in previously untreatable blood cancers, this breakthrough demonstrates medicine's shift toward programmable cell therapy. Cole examines engineering challenges, logic gates, and biology's transformation into executable code. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

Ryan Cole explores CAR-T therapy, where patients' immune cells are genetically reprogrammed to hunt cancer. With FDA-approved treatments achieving 83% remission rates in previously untreatable blood cancers, this breakthrough demonstrates medicine's shift toward programmable cell therapy. Cole examines engineering challenges, logic gates, and biology's transformation into executable code. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

NOW PLAYING

Biotech - Reprogrammed Cells That Hunt Cancer

0:00 26:32

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Talking Biotech with Dr. Kevin Folta Colabra Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering.Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050.Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics. State of Digital Clinical Trials Podcast Veeva State of Digital Clinical Trials is a Veeva podcast hosted by Manny Vazquez, Director, Clinical Data Strategy. Manny will be speaking to a series of expert guests from across pharma, biotech, and CROs to discuss their experiences, challenges, and ideas for the future of digital clinical trials. Will new technology make clinical trials more patient- and site-centric? The Biotech Startups Podcast Excedr The Biotech Startups Podcast by Excedr features weekly conversations with founders, scientists, and investors driving biotech innovation. Host Jon Chee dives into the challenges of building biotech startups, from pre-seed to IPO. New episodes every Monday and Thursday. GEN Podcasts Genetic Engineering and Biotechnology News Genetic Engineering & Biotechnology News (GEN) has retained its position as the premier biotech publication since its launch in 1981. GEN publishes a print edition monthly and has additional exclusive editorial content online, including news and analysis as well as webinars, videos, and polls. GEN's unique news and technology focus covers the entire bioproduct life cycle, including drug discovery, early-stage R&D, applied research (e.g., omics, biomarkers, and diagnostics), bioprocessing, and commercialization.GEN's print magazine, which also can easily be accessed online, includes feature articles on emerging technologies, product roundups, in-depth overviews from key scientific and bioindustry meetings, and industry-standard tutorials and technical articles on drug discovery, bioprocessing, and assay technologies. Hosted on Acast. See acast.co

Frequently Asked Questions

How long is this episode of Biotech?

This episode is 26 minutes long.

When was this Biotech episode published?

This episode was published on April 11, 2026.

What is this episode about?

Ryan Cole explores CAR-T therapy, where patients' immune cells are genetically reprogrammed to hunt cancer. With FDA-approved treatments achieving 83% remission rates in previously untreatable blood cancers, this breakthrough demonstrates medicine's...

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Biotech episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!